Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPTX |
---|---|---|
09:32 ET | 627 | 3.92 |
09:39 ET | 2000 | 3.905 |
09:52 ET | 1645 | 3.925 |
09:56 ET | 201 | 3.9 |
10:08 ET | 300 | 3.865 |
10:10 ET | 100 | 3.845 |
10:17 ET | 463 | 3.83 |
10:24 ET | 11244 | 3.83 |
10:28 ET | 1468 | 3.83 |
10:30 ET | 600 | 3.8 |
10:33 ET | 100 | 3.81 |
10:35 ET | 400 | 3.835 |
10:37 ET | 1961 | 3.91 |
11:00 ET | 300 | 3.865 |
11:11 ET | 406 | 3.87 |
11:22 ET | 300 | 3.9 |
11:24 ET | 100 | 3.92 |
11:44 ET | 200 | 3.92 |
11:45 ET | 1544 | 3.92 |
11:56 ET | 100 | 3.94 |
12:05 ET | 301 | 3.95 |
12:09 ET | 324 | 3.95 |
12:18 ET | 3632 | 3.8801 |
12:21 ET | 219 | 3.94 |
12:23 ET | 100 | 3.94 |
12:25 ET | 100 | 3.88 |
12:27 ET | 200 | 3.92 |
12:32 ET | 200 | 3.94 |
12:34 ET | 200 | 3.94 |
12:39 ET | 200 | 3.94 |
12:45 ET | 300 | 3.95 |
12:48 ET | 200 | 3.95 |
12:54 ET | 200 | 3.95 |
12:56 ET | 663 | 3.95 |
12:59 ET | 100 | 3.96 |
01:03 ET | 600 | 3.97 |
01:06 ET | 694 | 3.98 |
01:08 ET | 200 | 3.97 |
01:10 ET | 200 | 3.97 |
01:12 ET | 100 | 3.99 |
01:14 ET | 100 | 3.96 |
01:15 ET | 200 | 3.97 |
01:17 ET | 300 | 3.97 |
01:19 ET | 100 | 3.98 |
01:21 ET | 100 | 3.98 |
01:24 ET | 200 | 3.98 |
01:26 ET | 100 | 3.96 |
01:28 ET | 199 | 3.98 |
01:30 ET | 100 | 3.98 |
01:32 ET | 200 | 3.98 |
01:33 ET | 100 | 3.99 |
01:35 ET | 700 | 3.99 |
01:39 ET | 1390 | 3.97 |
01:42 ET | 100 | 3.98 |
01:46 ET | 700 | 3.95 |
01:48 ET | 300 | 3.95 |
01:50 ET | 100 | 3.98 |
01:51 ET | 500 | 3.95 |
01:55 ET | 1180 | 3.96 |
01:57 ET | 400 | 3.98 |
02:02 ET | 1329 | 3.97 |
02:04 ET | 627 | 3.95 |
02:20 ET | 8201 | 4.01 |
02:24 ET | 4204 | 4.04 |
02:26 ET | 19169 | 4.03 |
02:27 ET | 7876 | 4.02 |
02:31 ET | 3994 | 4.04 |
02:33 ET | 2999 | 3.97 |
02:36 ET | 300 | 3.99 |
02:38 ET | 200 | 3.93 |
02:40 ET | 100 | 3.94 |
02:42 ET | 300 | 3.98 |
02:44 ET | 100 | 3.955 |
02:47 ET | 100 | 3.955 |
02:54 ET | 500 | 3.97 |
02:56 ET | 400 | 3.95 |
02:58 ET | 100 | 3.98 |
03:02 ET | 200 | 3.98 |
03:07 ET | 125 | 3.98 |
03:12 ET | 100 | 4.01 |
03:14 ET | 100 | 4.01 |
03:16 ET | 100 | 4.01 |
03:20 ET | 100 | 3.97 |
03:25 ET | 200 | 3.97 |
03:30 ET | 100 | 3.92 |
03:34 ET | 530 | 3.9201 |
03:45 ET | 200 | 3.92 |
03:48 ET | 2100 | 3.96 |
03:52 ET | 400 | 3.98 |
03:54 ET | 2050 | 4.01 |
03:56 ET | 1200 | 3.995 |
03:57 ET | 621 | 3.96 |
03:59 ET | 12531 | 3.99 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Repare Therapeutics Inc | 169.8M | -3.6x | --- |
AVITA Medical Inc | 233.7M | -5.0x | --- |
Precision BioSciences Inc | 84.5M | -2.1x | --- |
Caribou Biosciences Inc | 169.8M | -1.4x | --- |
Metagenomi Inc | 241.3M | 0.0x | --- |
Innate Pharma SA | 213.1M | -24.5x | --- |
Repare Therapeutics Inc. is a clinical-stage precision oncology company focused on the development of synthetic lethality (SL)-based therapies for patients with cancer. The Company is engaged in the proprietary SL approach to the discovery and development of novel therapeutics. It uses its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop cancer therapies focused on genomic instability, including deoxyribonucleic acid (DNA) damage repair. The Company’s initial product candidate, camonsertib (RP-3500 or RG6526), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase (ATR) for the treatment of solid tumors with specific DNA damage repair-related genomic alterations, including those in the ataxia telangiectasia mutated kinase (ATM) gene as part of a network of 16 STEP2-identified genomic alterations. Its other pipeline includes Lunresertib PKMYT1 Inhibitor and RP-3467 polymerase theta (Pol0) Inhibitor.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $169.8M |
---|---|
Revenue (TTM) | $97.9M |
Shares Outstanding | 42.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.74 |
EPS | $-1.10 |
Book Value | $5.03 |
P/E Ratio | -3.6x |
Price/Sales (TTM) | 1.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -72.27% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.